BACKGROUND:Low-carbohydrate, ketogenic diets (LCKD) are effective for weight loss, but concerns remain regarding cardiovascular risk. The purpose of this study was to determine the effect of an LCKD program on serum lipoprotein subclasses. METHODS: This was a randomized, two-arm clinical trial in an outpatient research clinic involving overweight, hyperlipidemic community volunteers motivated to lose weight. Subjects were randomized to either an LCKD (n = 59) and nutritional supplementation (including fish, borage and flaxseed oil), or a low-fat, reduced-calorie diet (LFD, n = 60). The main outcomes were fasting serum lipoprotein subclasses determined by nuclear magnetic resonance analysis. RESULTS: The mean age of subjects was 44.9 years, the mean BMI was 34.4 kg/m(2), and 76% were women. Comparing baseline to 6 months, the LCKD group had significant changes in large VLDL (-78%), medium VLDL (-60%), small VLDL (-57%), LDL particle size (+2%), large LDL (+54%), medium LDL (-42%), small LDL (-78%), HDL particle size (+5%), large HDL (+21%), and LDL particle concentration (-11%). Compared with the LFD group, the LCKD group had greater reductions in medium VLDL (p = 0.01), small VLDL (p = 0.01) and medium LDL (p = 0.02), and greater increases in VLDL particle size (p = 0.01), large LDL (p = 0.004), and HDL particle size (p = 0.05). CONCLUSIONS: The LCKD with nutritional supplementation led to beneficial changes in serum lipid subclasses during weight loss. While the LCKD did not lower total LDL cholesterol, it did result in a shift from small, dense LDL to large, buoyant LDL, which could lower cardiovascular disease risk.
RCT Entities:
BACKGROUND:Low-carbohydrate, ketogenic diets (LCKD) are effective for weight loss, but concerns remain regarding cardiovascular risk. The purpose of this study was to determine the effect of an LCKD program on serum lipoprotein subclasses. METHODS: This was a randomized, two-arm clinical trial in an outpatient research clinic involving overweight, hyperlipidemic community volunteers motivated to lose weight. Subjects were randomized to either an LCKD (n = 59) and nutritional supplementation (including fish, borage and flaxseed oil), or a low-fat, reduced-calorie diet (LFD, n = 60). The main outcomes were fasting serum lipoprotein subclasses determined by nuclear magnetic resonance analysis. RESULTS: The mean age of subjects was 44.9 years, the mean BMI was 34.4 kg/m(2), and 76% were women. Comparing baseline to 6 months, the LCKD group had significant changes in large VLDL (-78%), medium VLDL (-60%), small VLDL (-57%), LDL particle size (+2%), large LDL (+54%), medium LDL (-42%), small LDL (-78%), HDL particle size (+5%), large HDL (+21%), and LDL particle concentration (-11%). Compared with the LFD group, the LCKD group had greater reductions in medium VLDL (p = 0.01), small VLDL (p = 0.01) and medium LDL (p = 0.02), and greater increases in VLDL particle size (p = 0.01), large LDL (p = 0.004), and HDL particle size (p = 0.05). CONCLUSIONS: The LCKD with nutritional supplementation led to beneficial changes in serum lipid subclasses during weight loss. While the LCKD did not lower total LDL cholesterol, it did result in a shift from small, dense LDL to large, buoyant LDL, which could lower cardiovascular disease risk.
Authors: Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen J Moore; George Davey Smith Journal: Cochrane Database Syst Rev Date: 2012-05-16
Authors: Kimberly A Gudzune; Ruchi S Doshi; Ambereen K Mehta; Zoobia W Chaudhry; David K Jacobs; Rachit M Vakil; Clare J Lee; Sara N Bleich; Jeanne M Clark Journal: Ann Intern Med Date: 2015-04-07 Impact factor: 25.391
Authors: Rosebud O Roberts; Lewis A Roberts; Yonas E Geda; Ruth H Cha; V Shane Pankratz; Helen M O'Connor; David S Knopman; Ronald C Petersen Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472
Authors: Wilson D Pace; Angela M Lanigan; Elizabeth W Staton; Deborah G Graham; Brian K Manning; L Miriam Dickinson; Caroline B Emsermann; Elizabeth E Stewart Journal: Ann Fam Med Date: 2013 Jul-Aug Impact factor: 5.166
Authors: Maximilian Bielohuby; Kerstin Stemmer; José Berger; Juliane Ramisch; Kathleen Smith; Jenna Holland; Kenneth Parks; Paul T Pfluger; Kirk M Habegger; Matthias H Tschöp; Randy J Seeley; Martin Bidlingmaier Journal: Obes Surg Date: 2012-01 Impact factor: 4.129
Authors: David J Decewicz; David M Neatrour; Amy Burke; Mary Jane Haberkorn; Heather L Patney; Marina N Vernalis; Darrell L Ellsworth Journal: Lipids Health Dis Date: 2009-06-29 Impact factor: 3.876
Authors: James D LeCheminant; Bryan K Smith; Eric C Westman; Mary C Vernon; Joseph E Donnelly Journal: Lipids Health Dis Date: 2010-06-01 Impact factor: 3.876
Authors: Jeff S Volek; Stephen D Phinney; Cassandra E Forsythe; Erin E Quann; Richard J Wood; Michael J Puglisi; William J Kraemer; Doug M Bibus; Maria Luz Fernandez; Richard D Feinman Journal: Lipids Date: 2008-12-12 Impact factor: 1.880
Authors: Lee Hooper; Carolyn D Summerbell; Rachel Thompson; Deirdre Sills; Felicia G Roberts; Helen Moore; George Davey Smith Journal: Cochrane Database Syst Rev Date: 2011-07-06